TrialThe Journal of international medical research2020

Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial.

Hyun-Sook Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.